These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 3744725)
41. Using the direct-injection model of early uveal melanoma hepatic metastasis to identify TPS as a potentially useful serum biomarker. Barak V; Frenkel S; Valyi-Nagy K; Leach L; Apushkin MA; Lin AY; Kalickman I; Baumann NA; Pe'er J; Maniotis AJ; Folberg R Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4399-402. PubMed ID: 17898257 [TBL] [Abstract][Full Text] [Related]
42. B-lymphocytes from melanoma patients and normal individuals react with melanoma cells but also with irrelevant antigens. Damato BE; Campbell AM; McGuire BJ; Lee WR; Foulds WS Br J Cancer; 1988 Aug; 58(2):182-5. PubMed ID: 3262365 [TBL] [Abstract][Full Text] [Related]
43. Generation of tumor cell-reactive human monoclonal antibodies using peripheral blood lymphocytes from actively immunized colorectal carcinoma patients. Haspel MV; McCabe RP; Pomato N; Janesch NJ; Knowlton JV; Peters LC; Hoover HC; Hanna MG Cancer Res; 1985 Aug; 45(8):3951-61. PubMed ID: 4016762 [TBL] [Abstract][Full Text] [Related]
44. Effect of an anti-CD54 (ICAM-1) monoclonal antibody (UV3) on the growth of human uveal melanoma cells transplanted heterotopically and orthotopically in SCID mice. Wang S; Coleman EJ; Pop LM; Brooks KJ; Vitetta ES; Niederkorn JY Int J Cancer; 2006 Feb; 118(4):932-41. PubMed ID: 16152588 [TBL] [Abstract][Full Text] [Related]
45. Xenogeneic monoclonal antibodies to cell surface antigens of equine lymphocytes. Newman MJ; Beegle KH; Antczak DF Am J Vet Res; 1984 Apr; 45(4):626-32. PubMed ID: 6375479 [TBL] [Abstract][Full Text] [Related]
46. Human uveal melanoma expresses NG2 immunoreactivity. Li Y; Madigan MC; Lai K; Conway RM; Billson FA; Crouch R; Allen BJ Br J Ophthalmol; 2003 May; 87(5):629-32. PubMed ID: 12714409 [TBL] [Abstract][Full Text] [Related]
47. A novel method for screening monoclonal antibodies reacting with antigenic determinants on soluble antigens; a reversed indirect-enzyme linked immunosorbent assay (RI-ELISA). Kohno N; Akiyama M; Kyoizumi S; Tanabe M; Oyama T; Yamakido M Hiroshima J Med Sci; 1987 Dec; 36(4):319-23. PubMed ID: 2452143 [No Abstract] [Full Text] [Related]
48. Tissue specificity of anti melanoma monoclonal antibodies analyzed on cell lines. Johnson JP; Riethmüller G Hybridoma; 1982; 1(4):381-5. PubMed ID: 6208134 [TBL] [Abstract][Full Text] [Related]
49. [Antitumor immunity in patients with melanoma of the uveal tract]. Cernák A; Kalafut F; Kusenda J; Novotná L Bratisl Lek Listy; 1989 Jul; 90(7):479-89. PubMed ID: 2790504 [TBL] [Abstract][Full Text] [Related]
50. Tumor-associated antibodies in the serum of patients with uveal melanoma. Brownstein S; Sheikh KM; Lewis MG Can J Ophthalmol; 1976 Apr; 11(2):147-54. PubMed ID: 1078333 [TBL] [Abstract][Full Text] [Related]
51. Decreased expression of HLA class II antigens on human uveal melanoma cells after in vivo X-ray irradiation. Jager MJ; van der Pol JP; de Wolff-Rouendaal D; de Jong PT; Ruiter DJ Am J Ophthalmol; 1988 Jan; 105(1):78-86. PubMed ID: 3276205 [TBL] [Abstract][Full Text] [Related]
52. Two antigens detected on human ocular melanomas with the mouse monoclonal antibodies 2/10SN and 10/12SN. Safi N; Kantor RR; Atkinson B; Moratz C; Wilt AR; Pancake S; Reba R; Mathieson BJ; Desgrez A Int J Cancer; 1992 Jul; 51(5):718-26. PubMed ID: 1612780 [TBL] [Abstract][Full Text] [Related]
53. Antigenic determinants in human malignant melanomas: study on a FAMMM patient with multiple melanomas. Césarini JP; Gaudry M; Musquin JL Prog Clin Biol Res; 1988; 256():561-72. PubMed ID: 2453068 [No Abstract] [Full Text] [Related]
55. Developmental changes in expression of a tumor-associated protein in the rat fetus. Runge SW; Larroya S; Schumm DE; Webb TE J Cell Biochem; 1989 Nov; 41(3):135-7. PubMed ID: 2613749 [TBL] [Abstract][Full Text] [Related]
56. Antibodies reacting with Simian Virus 40 capsid protein mimotopes in serum samples from patients affected by uveal melanoma. Bononi I; Perri P; Begnardi A; Martini A; Mazzoni E; Bosi S; Pietrobon S; Sebastiani A; Tognon M; Martini F J Hematol Oncol; 2014 Apr; 7():38. PubMed ID: 24886631 [TBL] [Abstract][Full Text] [Related]
57. Antigens in ocular and cutaneous melanomas. Folberg R; Donoso LA; Herlyn MF; Koprowski H Am J Ophthalmol; 1983 Sep; 96(3):394-5. PubMed ID: 6351625 [No Abstract] [Full Text] [Related]
58. Molecular heterogeneity and shedding of a high-molecular-mass melanoma-associated antigen identified with monoclonal antibodies. Ng AK; Giacomini P; Kantor R; Ferrone S Clin Chem; 1982 Dec; 28(12):2347-50. PubMed ID: 6183026 [TBL] [Abstract][Full Text] [Related]
59. Embryonic precancerous and cancerous human antigens recognized by monoclonal antibodies. Koprowski H Ciba Found Symp; 1983; 96():204-29. PubMed ID: 6343004 [TBL] [Abstract][Full Text] [Related]